XSWX
ASCN
Market cap231mUSD
Jul 22, Last price
5.53CHF
1D
-0.18%
1Q
-0.72%
Jan 2017
-65.44%
IPO
-94.28%
Name
Ascom Holding AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ascom Holding AG, alongside its affiliated companies, delivers specialized ICT and mobile workflow solutions to the healthcare sector worldwide. Its product lineup features sophisticated nurse call and patient monitoring systems, including teleCARE IP, which integrates nurse calling, alerts, secure messaging, patient tracking, and wander management, as well as Telligence, a dedicated patient response system. The company also provides Digistat software, a comprehensive suite for managing clinical workflows, and Unite software, a powerful workflow orchestration platform. Unite is designed to consolidate data and events from various source systems, delivering alerts, chat capabilities, and task management to users across multiple endpoint devices. Additionally, Ascom's hardware offerings include a range of mobile communication devices such as DECT and VoWiFi handsets, pagers, and IP-DECT solutions. Beyond its products, the company offers a full suite of services, encompassing expert consulting, system implementation, user training, ongoing support, and maintenance. These solutions cater to a diverse client base, from acute care hospitals to various enterprise sectors like retail, security, and hospitality, as well as long-term care facilities. Ascom Holding AG is headquartered in Baar, Switzerland.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||